2C2-NBOMe, also known as 2C-MMDA-2-NBOMe or NBOMe-MMDPEA-2, is a phenethylaminederivative from the 25-NB (NBOMe) family.[1][2] It is the NBOMe derivative of 2C-MMDA-2 (MMDPEA-2).[2]
It acts as a potentagonist at the serotonin5-HT2Areceptor with weaker activity at 5-HT2B and 5-HT2C, and produces a head-twitch response in animal studies which often correlates with potential for psychedelic effects in humans.[1][2]
It is related in structure to psychedelic phenethylamine derivatives such as MMDA-2 and lophophine (MMDPEA) and is the first phenethylamine derivative with a methylenedioxy substitution on the phenyl ring but no alkyl substitution on the alpha carbon, that has been shown to produce psychedelic-appropriate responding in animals.[1][2]
The drug was first described in the literature by Jason Wallach and colleagues in 2022 and 2023.[1][2] It is a controlled substance in Canada under phenethylamine blanket-ban language.[3] The drug is not an explicitly controlled substance in the United States,[4] but could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.
I cannot fulfill this request. 2C2-NBOMe (Cas 497096-69-2) is a research chemical from the NBOMe family, a class of substances known for high potency, toxicity, and unpredictable effects, which has resulted in several fatalities
.
Wikipedia +4
These compounds are generally not approved for human consumption, and many countries have strict regulations or bans on their possession and sale.
If you are a researcher looking for compounds for forensic or analytical purposes, you should source such materials through licensed, legitimate scientific suppliers that adhere to regulatory guidelines, such as DEA registration in the United States.
Cayman Chemical
2C2-NBOMe - Wikipedia
2C2-NBOMe, also known as 2C-MMDA-2-NBOMe or NBOMe-MMDPEA-2, is a phenethylamine derivative from the 25-NB (NBOMe) family.
Wikipedia
25I-NBOMe (hydrochloride) (exempt preparation)
This product has been formulated as an exempt preparation which meets criteria established by the US DEA · Possession of a DEA Con...
Cayman Chemical
N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOME): A ...
21 Jan 2021 — 25I-NBOMe is the first synthesized and one of the most common compound from NBOMes. Knowledge of pharmacological properties of 25I...
National Institutes of Health (.gov)
Show all
Show more
37 Results | NBOMe | Search
Cayman Chemical
https://www.caymanchem.com › search
An internal standard for the quantification of 25I-NBOMe · Purity: ≥99% deuterated forms (d1-d3) · Schedule: I · Formulation: A crystalline ...Read more
Missing: 497096-69-2 | Show results with: 497096-69-2
2C-MMDA-2
Wikipedia
https://en.wikipedia.org › wiki
2C-MMDA-2 (2C-2), also known as MMDPEA-2 or 6-methoxy-MDPEA, as well as 2-methoxy-4,5-methylenedioxyphenethylamine, is a serotonin 5-HT2 receptor agonist of ...Read more
N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOME): A ...
National Institutes of Health (.gov)
https://pubmed.ncbi.nlm.nih.gov › ...
by K Kamińska · 2021 · Cited by 12 — 25I-NBOMe is the first synthesized and one of the most common compound from NBOMes. Knowledge of pharmacological properties of 25I-NBOMe is very limited so far.Read more
Missing: 497096-69-2 | Show results with: 497096-69-2
25I-NBOMe (hydrochloride) (exempt preparation)
Cayman Chemical
https://www.caymanchem.com › product
This product has been formulated as an exempt preparation which meets criteria established by the US DEA · Possession of a DEA Controlled Substance registration ...Read more
Missing: 497096-69-2 | Show results with: 497096-69-2
2C2-NBOMe
Wikipedia
https://en.wikipedia.org › wiki › 2C2-NBOMe
2C2-NBOMe, also known as 2C-MMDA-2-NBOMe or NBOMe-MMDPEA-2, is a phenethylamine derivative from the 25-NB (NBOMe) family.Read more
Reviews
There are no reviews yet.